942 related articles for article (PubMed ID: 14627915)
1. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
2. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
Zhu ZX; Fan LY; Wang Q
Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
[TBL] [Abstract][Full Text] [Related]
6. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.
Takayama T; Morelli AE; Robbins PD; Tahara H; Thomson AW
Gene Ther; 2000 Aug; 7(15):1265-73. PubMed ID: 10918497
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients.
Lu L; Gambotto A; Lee WC; Qian S; Bonham CA; Robbins PD; Thomson AW
Gene Ther; 1999 Apr; 6(4):554-63. PubMed ID: 10476215
[TBL] [Abstract][Full Text] [Related]
9. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
Niimi M; Pearson TC; Larsen CP; Alexander DZ; Hollenbaugh D; Aruffo A; Linsley PS; Thomas E; Campbell K; Fanslow WC; Geha RS; Morris PJ; Wood KJ
J Immunol; 1998 Nov; 161(10):5331-7. PubMed ID: 9820506
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells conditioned with NK026680 prolong cardiac allograft survival in mice.
Shibasaki S; Yamashita K; Yanagawa Y; Goto R; Wakayama K; Hirokata G; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Todo S
Transplantation; 2012 Jun; 93(12):1229-37. PubMed ID: 22643332
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
13. Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival.
Zhang M; Wang Q; Liu Y; Sun Y; Ding G; Fu Z; Min Z; Zhu Y; Cao X
J Mol Med (Berl); 2004 Apr; 82(4):240-9. PubMed ID: 15168681
[TBL] [Abstract][Full Text] [Related]
14. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
15. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
16. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
17. Anti-ICAM-1 antibody and CTLA-4Ig synergistically enhance immature dendritic cells to induce donor-specific immune tolerance in vivo.
Wang Q; Zhang M; Ding G; Liu Y; Sun Y; Wang J; Zhang W; Fu Z; Cao X
Immunol Lett; 2003 Nov; 90(1):33-42. PubMed ID: 14611905
[TBL] [Abstract][Full Text] [Related]
18. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
19. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
[TBL] [Abstract][Full Text] [Related]
20. Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells.
Min WP; Zhou D; Ichim TE; Xia X; Zhang X; Yang J; Huang X; Garcia B; Dutartre P; Jevnikar AM; Strejan GH; Zhong R
Transplantation; 2003 Apr; 75(8):1160-5. PubMed ID: 12717196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
